QuiVad

Home / France / Innate Pharma

Innate Pharma

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 4.07% on April 4, 2017. The shaded band is the year shown above.

April 15, 2014 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

330 disclosures on record for this share.
DateFund% of capitalEnd of publication
January 28, 2022Voleon Capital Management LP0.49%February 1, 2022
January 26, 2022Voleon Capital Management LP0.57%February 1, 2022
January 24, 2022Voleon Capital Management LP0.68%February 1, 2022
January 4, 2022Voleon Capital Management LP0.70%February 1, 2022
December 29, 2021Voleon Capital Management LP0.60%February 1, 2022
December 21, 2021Voleon Capital Management LP0.50%February 1, 2022
December 17, 2020Citadel Advisors LLC0.47%December 21, 2020
December 14, 2020Citadel Advisors LLC0.55%December 21, 2020
October 30, 2020Voleon Capital Management LP0.46%November 3, 2020
October 29, 2020Citadel Advisors LLC0.49%November 2, 2020
October 28, 2020Citadel Advisors LLC0.51%November 2, 2020
October 27, 2020Voleon Capital Management LP0.50%November 3, 2020
October 22, 2020Citadel Advisors LLC0.49%October 26, 2020
October 21, 2020Citadel Advisors LLC0.50%October 26, 2020
September 25, 2020Citadel Advisors LLC0.43%September 29, 2020
September 22, 2020Citadel Advisors LLC0.57%September 29, 2020
September 21, 2020Citadel Advisors LLC0.61%September 29, 2020
September 18, 2020Citadel Advisors LLC0.59%September 29, 2020
September 16, 2020Rubric Capital Management LP0.23%September 21, 2020
September 14, 2020Citadel Advisors LLC0.68%September 29, 2020
September 14, 2020Rubric Capital Management LP0.51%September 21, 2020
September 11, 2020Citadel Advisors LLC0.70%September 29, 2020
September 9, 2020Citadel Advisors LLC0.61%September 29, 2020
June 2, 2020Voleon Capital Management LP0.48%June 4, 2020
May 26, 2020Voleon Capital Management LP0.59%June 4, 2020
March 18, 2020Voleon Capital Management LP0.79%June 4, 2020
March 4, 2020Voleon Capital Management LP0.80%June 4, 2020
March 3, 2020Voleon Capital Management LP0.79%June 4, 2020
March 2, 2020Voleon Capital Management LP0.80%June 4, 2020
February 25, 2020Voleon Capital Management LP0.70%June 4, 2020
February 24, 2020Voleon Capital Management LP0.69%June 4, 2020
February 13, 2020Voleon Capital Management LP0.78%June 4, 2020
February 3, 2020Voleon Capital Management LP0.85%June 4, 2020
January 22, 2020Voleon Capital Management LP0.97%June 4, 2020
January 16, 2020Voleon Capital Management LP1.00%June 4, 2020
January 13, 2020Voleon Capital Management LP0.91%June 4, 2020
January 10, 2020Voleon Capital Management LP0.87%June 4, 2020
January 7, 2020Voleon Capital Management LP0.72%June 4, 2020
December 17, 2019Voleon Capital Management LP0.60%June 4, 2020
December 6, 2019Voleon Capital Management LP0.50%June 4, 2020
November 8, 2018Numeric Investors LLC0.45%November 12, 2018
October 30, 2018Numeric Investors LLC0.59%November 12, 2018
August 8, 2018Numeric Investors LLC0.60%November 12, 2018
July 31, 2018Numeric Investors LLC0.57%November 12, 2018
July 26, 2018Numeric Investors LLC0.60%November 12, 2018
June 14, 2018Numeric Investors LLC0.52%November 12, 2018
April 12, 2018GSA Capital Partners LLP0.48%April 16, 2018
March 5, 2018GSA Capital Partners LLP0.58%April 16, 2018
February 9, 2018GSA Capital Partners LLP0.69%April 16, 2018
January 25, 2018GSA Capital Partners LLP0.70%April 16, 2018

Other companies sold short in France

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Innate Pharma, source AMF, data as at January 28, 2022, https://www.quivad.com/action/innate-pharma